Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）

NCT06368882 is registered in ClinicalTrials.gov with First Affiliated Hospital of Wenzhou Medical University as lead sponsor.

NCT NCT06368882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06368882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）
Lead sponsor
First Affiliated Hospital of Wenzhou Medical University
Phase
Phase 4
Overall status
Recruiting
Start date
January 1, 2024
Completion date
December 31, 2028
Enrollment
1,500 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b, nonalcoholic fatty liver disease